Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Diabetes/Metabolism Research and Reviews
|
April 27, 2020
DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19?
Rocky Strollo, Paolo Pozzilli
Immunotherapy
|
August 3, 2012
Immunotherapy for Type 1 diabetes: getting beyond a negative first impression
Paolo Pozzilli, Rocky Strollo
Journal of Diabetes Investigation
|
May 21, 2014
One size does not fit all glycemic targets for type 2 diabetes
Paolo Pozzilli, Rocky Strollo, Enzo Bonora
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
June 15, 2010
Natural history and immunopathogenesis of type 1 diabetes
Paolo Pozzilli, Rocky Strollo, Ilaria Barchetta
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
July 15, 2010
Natural history and immunopathogenesis of type 1 diabetes
Paolo Pozzilli, Rocky Strollo, Ilaria Barchetta
Diabetes Care
|
July 17, 2020
Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive Individuals. Diabetes Care 2020;43:913-917
Ghadeer E Alhamar, Rocky Strollo, Paolo Pozzilli
Frontiers in Endocrinology
|
December 20, 2021
Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
Flavia Tramontana, Sofia Battisti, Nicola Napoli, et al.
Endocrine
|
July 8, 2020
The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond
Flavia Tramontana, Nicola Napoli, Ghada El-Hajj Fuleihan, et al.
Diabetologia
|
May 21, 2017
Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children
Rocky Strollo, Chiara Vinci, Nicola Napoli, et al.
Diabetes Research and Clinical Practice
|
September 18, 2020
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
Rocky Strollo, Ernesto Maddaloni, Marco Dauriz, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Diabetes/Metabolism Research and Reviews
|
April 27, 2020
DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19?
Rocky Strollo, Paolo Pozzilli
Immunotherapy
|
August 3, 2012
Immunotherapy for Type 1 diabetes: getting beyond a negative first impression
Paolo Pozzilli, Rocky Strollo
Journal of Diabetes Investigation
|
May 21, 2014
One size does not fit all glycemic targets for type 2 diabetes
Paolo Pozzilli, Rocky Strollo, Enzo Bonora
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
June 15, 2010
Natural history and immunopathogenesis of type 1 diabetes
Paolo Pozzilli, Rocky Strollo, Ilaria Barchetta
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
July 15, 2010
Natural history and immunopathogenesis of type 1 diabetes
Paolo Pozzilli, Rocky Strollo, Ilaria Barchetta
Diabetes Care
|
July 17, 2020
Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive Individuals. Diabetes Care 2020;43:913-917
Ghadeer E Alhamar, Rocky Strollo, Paolo Pozzilli
Frontiers in Endocrinology
|
December 20, 2021
Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
Flavia Tramontana, Sofia Battisti, Nicola Napoli, et al.
Endocrine
|
July 8, 2020
The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond
Flavia Tramontana, Nicola Napoli, Ghada El-Hajj Fuleihan, et al.
Diabetologia
|
May 21, 2017
Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children
Rocky Strollo, Chiara Vinci, Nicola Napoli, et al.
Diabetes Research and Clinical Practice
|
September 18, 2020
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
Rocky Strollo, Ernesto Maddaloni, Marco Dauriz, et al.
Page
of 6